These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19746679)

  • 1. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
    Woodhall KE; Goldman MP; Gold MH; Biron J
    J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
    Schlessinger J; Kenkel J; Werschler P
    Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
    Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary effects of topical antiaging treatments in conjunction with aesthetic procedures.
    Bruce S
    J Drugs Dermatol; 2008 Feb; 7(2 Suppl):s23-7. PubMed ID: 18404868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
    J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma.
    Goldman MP; Gold MH; Palm MD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Dermatol Surg; 2011 Feb; 37(2):224-33. PubMed ID: 21269349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
    Yoshimura K; Momosawa A; Watanabe A; Sato K; Matsumoto D; Aiba E; Harii K; Yamamoto T; Aoyama T; Iga T
    Dermatol Surg; 2002 Dec; 28(12):1153-7; discussion 1158. PubMed ID: 12472496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial.
    Kang S; Bergfeld W; Gottlieb AB; Hickman J; Humeniuk J; Kempers S; Lebwohl M; Lowe N; McMichael A; Milbauer J; Phillips T; Powers J; Rodriguez D; Savin R; Shavin J; Sherer D; Silvis N; Weinstein R; Weiss J; Hammerberg C; Fisher GJ; Nighland M; Grossman R; Nyirady J
    Am J Clin Dermatol; 2005; 6(4):245-53. PubMed ID: 16060712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating photodamage of the décolletage area with a novel copper zinc malonate complex plus hydroquinone and tretinoin.
    Leyden JJ; Parr L
    J Drugs Dermatol; 2010 Mar; 9(3):220-6. PubMed ID: 20232582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
    J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
    Jarratt M
    Cutis; 2004 Nov; 74(5):319-22. PubMed ID: 15605971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial.
    Weiss JS; Shavin JS; Nighland M; Grossman R
    Cutis; 2006 Dec; 78(6):426-32. PubMed ID: 17243432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging.
    Dover JS; Bhatia AC; Stewart B; Arndt KA
    Arch Dermatol; 2005 Oct; 141(10):1247-52. PubMed ID: 16230562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical retinoic acid (tretinoin) for photoaging: conceptions and misperceptions.
    Kligman AM
    Cutis; 1996 Mar; 57(3):142-4. PubMed ID: 8882009
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of 5-aminolevulinic acid-mediated photorejuvenation of neck skin.
    Zhang HY; Ji J; Tan YM; Zhang LL; Wang XJ; Wang PR; Yang DG; Shi L; Huang Z; Chen SY; Wang XL
    Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):498-509. PubMed ID: 25461963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.